Recombinant Rat Orm1 Protein，His

Orm1, or ORM1 (Orosomucoid 1), is a highly glycosylated plasma protein primarily synthesized by the liver and classified as an acute-phase reactant. It has garnered significant attention in biomedical research due to its involvement in various physiological and pathological processes, including immune response, inflammation, and tissue repair. The protein is known to exhibit immunomodulatory effects, potentially influencing the outcome of diseases such as cancer, autoimmune disorders, and infectious diseases. Moreover, elevated levels of Orm1 have been associated with inflammatory conditions and certain malignancies, making it a potential biomarker for disease states. The study of recombinant Orm1 protein offers valuable insights into its structural properties, functional roles, and interactions with other biomolecules. By expressing Orm1 in heterologous systems, researchers can obtain large quantities of pure protein for detailed investigation, including its role in modulating human immune responses. Understanding the mechanisms through which Orm1 functions may open new avenues for therapeutic interventions and diagnostic applications. Overall, the research on Orm1 recombinant protein continues to enhance our knowledge of its biological significance and potential clinical implications, underscoring its importance in the context of health and disease.